Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle

Molecular and Cellular Biology

Volumn 32, Issue 16, 2012, Pages 3333-3346

  Blättler, Sharon M ^a,b   Verdeguer, Francisco ^a,b   Liesa, Marc ^c   Cunningham, John T ^a,b   Vogel, Rutger O ^a,b   Chim, Helen ^a,b   Liu, Huifei ^b   Romanino, Klaas ^d   Shirihai, Orian S ^c   Vazquez, Francisca ^a,b   Rüegg, Markus A ^d   Shi, Yang ^b   Puigserver, Pere ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; MAMMALIAN TARGET OF RAPAMYCIN; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RAPAMYCIN; TRANSCRIPTION FACTOR YY1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE TOLERANCE; GENE ACTIVATION; GENE INACTIVATION; HISTOLOGY; KNOCKOUT MOUSE; MITOCHONDRIAL MYOPATHY; MOUSE; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT STATURE; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ALLELES; ANIMALS; ENERGY METABOLISM; HEK293 CELLS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIA, MUSCLE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; YY1 TRANSCRIPTION FACTOR;

EID: 84865117354     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00337-12     Document Type: Article

References (52)

1. Affar EB, et al. 2006. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol. Cell. Biol. 26:3565-3581.
2. Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. 2003. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 22:1347-1358.
3. Austen M, Luscher B, Luscher-Firzlaff JM. 1997. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J. Biol. Chem. 272:1709-1717.
4. Bentzinger CF, et al. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411-424.
5. Blättler SM, et al. 2012. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab. 15:505-517.
6. Cai Y, et al. 2007. YY1 functions with INO80 to activate transcription. Nat. Struct. Mol. Biol. 14:872-874.
7. Calvaruso MA, Smeitink J, Nijtmans L. 2008. Electrophoresis techniques to investigate defects in oxidative phosphorylation. Methods 46:281-287.
8. Calvo SE, Mootha VK. 2010. The mitochondrial proteome and human disease. Annu. Rev. Genomics Hum. Genet. 11:25-44.
9. Canto C, Auwerx J. 2010. AMP-activated protein kinase and its downstream transcriptional pathways. Cell. Mol. Life Sci. 67:3407-3423.
10. Chappell JB, Perry SV. 1954. Biochemical and osmotic properties of skeletal muscle mitochondria. Nature 173:1094-1095.
11. Cunningham JT, et al. 2007. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 450: 736-740.
12. Eichner LJ, Giguere V. 2011. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11:544-552.
13. Finck BN, Kelly DP. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116:615-622.
14. Goffart S, Wiesner RJ. 2003. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp. Physiol. 88:33-40.
15. Handschin, C, Spiegelman BM. 2011. PGC-1 coactivators and the regulation of skeletal muscle fiber-type determination. Cell Metab. 13:351-352.
16. He Y, et al. 2007. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217-230.
17. Hock MB, Kralli A. 2009. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 71:177-203.
18. Kagey MH, Melhuish TA, Wotton D. 2003. The polycomb protein Pc2 is a SUMO E3. Cell 113:127-137.
19. Kelly DP, Scarpulla RC. 2004. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18:357-368.
20. Li S, et al. 2005. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. U. S. A. 102:1082-1087.
21. Liesa M, et al. 2008. Mitochondrial fusion is increased by the nuclear coactivator PGC-1α. PLoS One 3:e3613. doi:10.1371/journal.pone.0003613.
22. Liesa M, et al. 2011. Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion. Circulation 124:806-813.
23. Lin J, et al. 2002. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418:797-801.
24. Little JP, Safdar A, Benton CR, Wright DC. 2011. Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis. Appl. Physiol. Nutr. Metab. 36:598-607.
25. Liu H, et al. 2007. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev. 21:1179-1189.
26. Mootha VK, et al. 2003. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115:629-640.
27. Mootha VK, et al. 2004. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 101:6570-6575.
28. Mootha VK, et al. 2003. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
29. Narkar VA, et al. 2011. Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRα. Cell Metab. 13:283-293.
30. Puigserver P, Spiegelman BM. 2003. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24:78-90.
31. Puigserver P, et al. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839.
32. Rezai-Zadeh N, et al. 2003. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev. 17:1019-1029.
33. Risson V, et al. 2009. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187:859-874.
34. Sahin E, et al. 2011. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470:359-365.
35. Scarpulla RC. 2011. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813:1269-1278.
36. Scarpulla RC. 2008. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88:611-638.
37. Schreiber SN, et al. 2004. The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. U. S. A. 101:6472-6477.
38. Subramanian A, et al. 2005. Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
39. Tarnopolsky MA, Raha S. 2005. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med. Sci. Sports Exerc. 37: 2086-2093.
40. Thomas MJ, Seto E. 1999. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236:197-208.
41. Wallace DC, Fan W. 2009. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 23:1714-1736.
42. Wallace DC, Fan W, Procaccio V. 2010. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 5:297-348.
43. Weill L, Shestakova E, Bonnefoy E. 2003. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J. Virol. 77:2903-2914.
44. Wenz T, Diaz F, Spiegelman BM, Moraes CT. 2008. Activation of the PPAR/PGC-1α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 8:249-256.
45. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. 2009. Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 106:20405-20410.
46. Wilkinson FH, Park K, Atchison ML. 2006. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc. Natl. Acad. Sci. U. S. A. 103:19296-19301.
47. Wolny S, McFarland R, Chinnery P, Cheetham T. 2009. Abnormal growth in mitochondrial disease. Acta Paediatr. 98:553-554.
48. Wu H, et al. 2002. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296:349-352.
49. Wu Z, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124.
50. Xi H, et al. 2007. Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. Genome Res. 17:798-806.
51. Yao YL, Yang WM, Seto E. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21:5979-5991.
52. Ylikallio E, Suomalainen A. 2012. Mechanisms of mitochondrial diseases. Ann. Med. 44:41-59.